|
Volumn 21, Issue 4 A, 2001, Pages 2597-2600
|
Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner
a a a,a a a a a
a
KEIO UNIVERSITY
(Japan)
|
Author keywords
Breast cancer; Combination therapy; Docetaxel; Synergism; Tetrahydropyranyladriamycin
|
Indexed keywords
ANTHRACYCLINE DERIVATIVE;
DOCETAXEL;
PIRARUBICIN;
TAXANE DERIVATIVE;
ADULT;
ANIMAL EXPERIMENT;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG RESPONSE;
FEMALE;
HUMAN;
HUMAN TISSUE;
IN VITRO STUDY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TISSUE CULTURE;
TUMOR XENOGRAFT;
ADULT;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG SYNERGISM;
FEMALE;
HUMANS;
INHIBITORY CONCENTRATION 50;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, NUDE;
PACLITAXEL;
TAXOIDS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035153471
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (20)
|